Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

United Arab Emirates flag United Arab Emirates · Delayed Price · Currency is AED
1.060
+0.010 (0.95%)
At close: May 22, 2026
Market Cap1.22B -23.2%
Revenue (ttm)1.07B +13.8%
Net Income81.40M -51.7%
EPS0.07 -51.7%
Shares Out1.16B
PE Ratio17.60
Forward PE13.25
Dividendn/a
Ex-Dividend Daten/a
Volume608,701
Average Volume2,123,939
Open1.050
Previous Close1.050
Day's Range1.030 - 1.060
52-Week Range0.956 - 1.610
Beta-0.14
RSI49.64
Earnings DateMay 22, 2026

About ADX:JULPHAR

Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally. The company operates through Manufacturing, Trading, Investments, and Others segment. It offers generic medicines for pain and inflammation, antiviral, respiratory, anti-infectives, immunosuppressants and selective immunosuppressants, cardio care, CNS and psychiatry, vitamins and supplements, wo... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Employees 2,400
Stock Exchange Abu Dhabi Securities Exchange
Ticker Symbol JULPHAR
Full Company Profile

Financial Performance

In 2025, ADX:JULPHAR's revenue was 1.08 billion, an increase of 8.40% compared to the previous year's 992.20 million. Earnings were 172.20 million, an increase of 286.10%.

Financial Statements